Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.

Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension. Chest. 2016 Nov; 150(5):1059-1068.

View in: PubMed

subject areas

Double-Blind Method
Double-Blind Method
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Pulmonary Embolism
Pulmonary Embolism
Recurrence
Recurrence
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Rivaroxaban
Rivaroxaban
Secondary Prevention
Secondary Prevention
Survival Rate
Survival Rate
Treatment Outcome
Treatment Outcome
Venous Thromboembolism
Venous Thromboembolism

authors with profiles

Gary E Raskob